In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J's venture arm joins backers in 23andMe's $31mm Series C

Executive Summary

New investor Johnson & Johnson Development Corp. has joined current shareholders New Enterprise Associates and Google Ventures, plus five undisclosed backers in 23andMe Inc.'s (personalized genetics) $22.2mm Series C venture round. According to the Form D filing, the company could bring in another $7.8mm before closing the financing.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register